Nuance Investments, LLC Bioventus Inc. Transaction History

Nuance Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$6.82 - $13.82 $5.13 Million - $10.4 Million	-751,954 Reduced 55.61%	600,147 $4.09 Million
Q1 2022 May 13, 2022	BUY	$11.65 - $15.28 $897,760 - $1.18 Million	77,061 Added 6.04%	1,352,101 $19.1 Million
Q4 2021 Feb 09, 2022	BUY	$12.37 - $16.77 $1.53 Million - $2.07 Million	123,283 Added 10.7%	1,275,040 $18.5 Million
Q3 2021 Nov 15, 2021	BUY	$13.7 - $17.25 $6.23 Million - $7.85 Million	454,907 Added 65.28%	1,151,757 $16.3 Million
Q2 2021 Aug 10, 2021	BUY	$13.75 - $18.8 $9.58 Million - $13.1 Million	696,850 New	696,850 $12.3 Million

141

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $655M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Nuance Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuance Investments, LLC with notifications on news.